(Q35874915)

10 August 2017

1 reference

title

Chromosomal regulation by MeCP2: structural and enzymatic considerations (English)

1 reference

10 August 2017

Bowen NJ

1

1 reference

10 August 2017

Palmer MB

series ordinal

2

1 reference

10 August 2017

Wade PA

series ordinal

3

1 reference

10 August 2017

publication date

1 September 2004

1 reference

Cellular and Molecular Life Sciences

10 August 2017

published in

1 reference

10 August 2017

volume

61

1 reference

10 August 2017

issue

17

1 reference

10 August 2017

page(s)

2163-2167

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-004-4177-x

10 August 2017

exact match

0 references

cites work

[Myocardial fibrosis: a cardiopathophysiologic Janus head]

1 reference

12 December 2020

Genetics and metabolic cardiomyopathies

1 reference

12 December 2020

The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes

1 reference

12 December 2020

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Socie

1 reference

12 December 2020

Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy

1 reference

12 December 2020

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

1 reference

12 December 2020

Cardiomyopathies: classification, diagnosis, and treatment

1 reference

12 December 2020

Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance

1 reference

12 December 2020

2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology.

1 reference

12 December 2020

Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy

1 reference

12 December 2020

American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro

1 reference

12 December 2020

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

1 reference

12 December 2020

Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy

1 reference

12 December 2020

Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy

1 reference

12 December 2020

Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases.

1 reference

12 December 2020

Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group

1 reference

12 December 2020

Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies

1 reference

12 December 2020

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

12 December 2020

Genetic cardiomyopathies. Lessons learned from humans, mice, and zebrafish

1 reference

12 December 2020

Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

1 reference

12 December 2020

Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram

1 reference

12 December 2020

Clinical and genetical heterogeneity of familial hypertrophic cardiomyopathy.

1 reference

12 December 2020

10.1007/S00018-004-4177-X

Identifiers

DOI

1 reference

10 August 2017

1 reference